betamethasone dipropionate NDC 72578-093

NDC codes

FDA NDC Directory

Product NDC (as listed)72578-093Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72578-0093Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72578-093-01	72578009301	1 TUBE in 1 CARTON (72578-093-01) / 15 g in 1 TUBEMarketed from Jul 20, 2020
72578-093-06	72578009306	1 TUBE in 1 CARTON (72578-093-06) / 45 g in 1 TUBEMarketed from Jul 20, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): betamethasone dipropionate
Generic name (nonproprietary): betamethasone dipropionate
Active ingredients: Betamethasone dipropionate — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Viona Pharmaceuticals Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214048
Marketing start: Jul 20, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 72578-093_48e480f9-2c41-4fd3-909b-a2490d7a1509SPL ID 48e480f9-2c41-4fd3-909b-a2490d7a1509SPL set ID 9adfb030-17c3-46eb-bf85-a90cabafd367RxCUI 197405UNII 826Y60901UUPC 0372578093013
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472578009301 followed by a unit qualifier and the quantity

Package 72578-0093-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 7, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214048

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214048
Product	Strength	Form · route	Labeler	Product NDC
betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Zydus Lifesciences Limited	70771-1550